Featured News Related News

Organic farming with gene editing: An oxymoron or a tool for sustainable agriculture?

A University of California, Berkeley professor stands at the front of the room, delivering her invited talk about the potential of genetic engineering. Her audience, full of organic farming advocates, listens uneasily. She notices a man get up from his [...]

BioBricks Foundation Announces Publication of OpenMTA in Nature Biotechnology

A new, easy-to-use legal tool enabling open exchange of biological materials is launched. SAN FRANCISCO, Oct. 11, 2018 /PRNewswire/ -- The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing, and innovation in biology and biotechnology. Material Transfer [...]

By | October 12th, 2018|Featured News, Synthetic Biology News, Synthetic Biology Stack|

A clash of titans: DIY Bio met the homebrew computer club at SynBioBeta 2018

Steve Wozniak: the man who co-founded Apple, a household name. George Church: the synthetic biologist and professor, a mammoth contributor to science, both figuratively and literally. The opening night of SynBioBeta 2018 was the embodiment of technology meeting biology, with [...]

By | October 10th, 2018|Featured News, Individual Profile, Synthetic Biology News|

Meet Staph epidermidis, gatekeeper of healthy skin

This story is brought to you by Azitra, a preclinical stage biotechnology company combining the power of the microbiome with cutting-edge genetic engineering to treat skin disease. With all of the talk about CRISPR and genome editing these days, it [...]

A Pulitzer Prize for Evolutionary Biology

The Nobel Prize in Chemistry was awarded yesterday to three recipients for discovering methods in controlling and speeding enzyme and antibody evolution. Frances H. Arnold, a professor of chemical engineering at the California Institute of Technology, was awarded one half [...]

By | October 4th, 2018|Featured News, Synthetic Biology News|

Highlights of SynBioBeta 2018 Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M

John Cumbers took the stage to welcome our community and announce that Twist Bioscience filed for a $86.3M IPO! He also mentioned that the Nobel Prize in chemistry was awarded jointly to three scientists whose work contributed to the foundation [...]

By | October 3rd, 2018|Featured News, Synthetic Biology News|
tadalafiltablets findviagra.com http://xanaxonlinebuy.com/